This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages without signing in

Follow-up for hyperthyroidism

Authoring team

Follow-up and monitoring of hyperthyroidism

Monitoring after radioactive iodine treatment

  • consider measuring TSH, FT4 and FT3 levels in adults, children and young people every 6 weeks for the first 6 months after radioactive iodine treatment until TSH is within the reference range.
  • for adults, children and young people who have hypothyroidism after radioactive iodine treatment and are not on anti-thyroid drugs, offer levothyroxine replacement therapy and with dosage and monitoring as per management of primary hypothyroidism
  • for adults, children and young people with TSH in the reference range 6 months after radioactive iodine treatment, consider measuring TSH (with cascading) at 9 months and 12 months after treatment.
  • for adults, children and young people with TSH in the reference range 12 months after radioactive iodine treatment, consider measuring TSH (with cascading) every 6 months unless they develop hypothyroidism (then follow advice above)

If hyperthyroidism persists after radioactive iodine treatment in adults, children and young people, consider anti-thyroid drugs until the 6-month appointment.

If hyperthyroidism persists 6 months after radioactive iodine treatment in adults, children and young people, consider further treatment

Monitoring after surgery

Offer levothyroxine to adults, children and young people after a total thyroidectomy with dosage and monitoring as per management of primary hypothyroidism

Consider measuring TSH and FT4 at 2 and 6 months after surgery, and then TSH (with cascading) once a year for adults, children and young people who have had a hemithyroidectomy

Monitoring of anti-thyroid drugs

For adults, children and young people who are taking anti-thyroid drugs for hyperthyroidism, consider measuring:

  • TSH, FT4 and FT3 every 6 weeks until their TSH is within the reference range,
  • then TSH (with cascading) every 3 months until anti-thyroid drugs are stopped.

Do not monitor full blood count and liver function for adults, children and young people taking anti-thyroid drugs for hyperthyroidism unless there is a clinical suspicion of agranulocytosis or liver dysfunction.

For adults who have stopped anti-thyroid drugs, consider measuring:

  • TSH (with cascading) within 8 weeks of stopping the drug,
  • then TSH (with cascading) every 3 months for a year,
  • then TSH (with cascading) once a year

For children and young people who have stopped anti-thyroid drugs, consider measuring:

  • TSH, FT4 and FT3 within 8 weeks of stopping the drug,
  • then TSH, FT4 and FT3 every 3 months for the first year,
  • then TSH (with cascading) every 6 months for the second year,
  • then TSH (with cascading) once a year

Reference:

  1. Thyroid disease: assessment and management. NICE guideline NG145. Published: 20 November 2019 Last updated: 12 October 2023

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.